Universus Photo Imagings Limited (NSE:UNIVPHOTO)
383.00
+15.40 (4.19%)
Jul 14, 2026, 3:27 PM IST
Universus Photo Imagings Revenue
In the fiscal year ending March 31, 2026, Universus Photo Imagings had annual revenue of 187.80M INR, down -23.65%. Universus Photo Imagings had revenue of 46.40M in the quarter ending March 31, 2026, with 3.90% growth.
Revenue
187.80M
Revenue Growth
-23.65%
P/S Ratio
22.45
Revenue / Employee
n/a
Employees
42
Market Cap
4.22B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 187.80M | -58.16M | -23.65% |
| Mar 31, 2025 | 245.96M | -78.52M | -24.20% |
| Mar 31, 2024 | 324.48M | -107.68M | -24.92% |
| Mar 31, 2023 | 432.16M | -129.46M | -23.05% |
| Mar 31, 2022 | 561.62M | 92.02M | 19.60% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 584.62B |
| Cipla | 278.28B |
| Apollo Hospitals Enterprise | 252.29B |
| Divi's Laboratories | 105.60B |
| Haleos Labs | 3.34B |
| Valiant Laboratories | 2.37B |
| Infinium Pharmachem | 1.90B |
| Bafna Pharmaceuticals | 1.51B |